Alternatively, elevated serum IL-17A has been reported in small cell lung cancer patients at mean levels of 24 pg/mL compared to 12 pg/mL in controls [44] and at comparable levels to other studies with mixed-staged NSCLC cohort [45,46,47]. This evidence concerns the gene IL17A and non-small cell lung carcinoma.